W STRATEGIES, LLC for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal. H.R.1625: Consolidated Appropriations Act, 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
H.R.1834: Cancer Care Payment Reform Act of 2017. Education about innovative contracting and value based payments. Synchronization and Nonadherence Correction (SYNC) Act. H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
Education about the 340(b) drug discount program including the CMS 340(b) CMP Rule. CDC Recommendations about flu treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.